Form 4 for IOVA IOVANCE BIOTHERAPEUTICS, INC.
Accepted 2022-06-02 00:00:00 ET · period of report 2022-05-31 · accession 0001104659-22-067762 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-02 | 2022-05-31 | IOVA | Maynard Ryan D | Dir | P - Purchase | $6.75 | +7,500 | 7,500 | New | +$50.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-31 | P | A | 7,500 | $6.75 | 7,500 | D | — | — |